Management of adhesive small bowel obstruction: the results of a large retrospective study
- PMID: 37668744
- PMCID: PMC10480247
- DOI: 10.1007/s00384-023-04512-8
Management of adhesive small bowel obstruction: the results of a large retrospective study
Abstract
Background: Postoperative adhesive small bowel obstruction (SBO) is a frequent cause of hospital admission in a surgical department. Emergency surgery is needed in a majority of patients with bowel ischemia or peritonitis; most adhesive SBO can be managed nonoperatively. Many studies have investigated benefits of using oral water-soluble contrast to manage adhesive SBO. Treatment recommendations are still controversial.
Methods: We conducted an observational retrospective monocentric study to test our protocol of management of SBO using Gastrografin®, enrolling 661 patients from January 2008 to December 2021. An emergency surgery was performed in patients with abdominal tenderness, peritonitis, hemodynamic instability, major acute abdominal pain despite gastric decompression, or CT scan findings of small bowel ischemia. Nonoperative management was proposed to patients who did not need emergency surgery. A gastric decompression with a nasogastric tube was immediately performed in the emergency room for four hours, then the nasogastric tube was clamped and 100 ml of nondiluted oral Gastrografin® was administered. The nasogastric tube remained clamped for eight hours and an abdominal plain radiograph was taken after that period. Emergency surgery was then performed in patients who had persistent abdominal pain, onset of abdominal tenderness or vomiting during the clamping test, or if the abdominal plain radiograph did not show contrast product in the colon or the rectum. In other cases, the nasogastric tube was removed and a progressive refeeding was introduced, starting with liquid diet.
Results: Seventy-eight percent of patients with SBO were managed nonoperatively, including 183 (36.0%) who finally required surgery. Delayed surgery showed a complete small bowel obstruction in all patients who failed the conservative treatment, and a small bowel resection was necessary in 19 patients (10.0%): among them, only 5 had intestinal ischemia.
Conclusions: Our protocol is safe, and it is a valuable strategy in order to accelerate the decision-making process for management of adhesive SBO, with a percentage of risk of late small bowel resection for ischemia esteemed at 0.9%.
Keywords: Diagnostic protocol; Oral gastrografin; Small bowel obstruction; Water-soluble contrast agent.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Improving the management of acute adhesive small bowel obstruction with CT-scan and water-soluble contrast medium: a prospective study.Dis Colon Rectum. 2009 Nov;52(11):1869-76. doi: 10.1007/DCR.0b013e3181b35c06. Dis Colon Rectum. 2009. PMID: 19966635
-
Optimal Timing of First Abdominal Radiography after Gastrografin Administration for Small Bowel Obstruction.J Surg Res. 2020 Dec;256:193-197. doi: 10.1016/j.jss.2020.06.053. Epub 2020 Jul 22. J Surg Res. 2020. PMID: 32711175
-
Therapeutic value of gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective randomized trial.Ann Surg. 2002 Jul;236(1):1-6. doi: 10.1097/00000658-200207000-00002. Ann Surg. 2002. PMID: 12131078 Free PMC article. Clinical Trial.
-
Use of water-soluble contrast medium (gastrografin) does not decrease the need for operative intervention nor the duration of hospital stay in uncomplicated acute adhesive small bowel obstruction? A multicenter, randomized, clinical trial (Adhesive Small Bowel Obstruction Study) and systematic review.Surgery. 2017 May;161(5):1315-1325. doi: 10.1016/j.surg.2016.11.026. Epub 2017 Jan 10. Surgery. 2017. PMID: 28087066 Clinical Trial.
-
Water-soluble contrast medium (gastrografin) value in adhesive small intestine obstruction (ASIO): a prospective, randomized, controlled, clinical trial.World J Surg. 2008 Oct;32(10):2293-304. doi: 10.1007/s00268-008-9694-6. World J Surg. 2008. PMID: 18688562 Review.
Cited by
-
Prognostic value of CT findings for conservative treatment failure in adhesive small bowel obstruction.Emerg Radiol. 2025 Feb;32(1):33-40. doi: 10.1007/s10140-024-02276-4. Epub 2024 Jul 29. Emerg Radiol. 2025. PMID: 39073730
-
External validation of a CT score for predicting ischaemia in adhesive small-bowel obstruction.Eur Radiol. 2025 Jul;35(7):4203-4212. doi: 10.1007/s00330-025-11362-1. Epub 2025 Jan 24. Eur Radiol. 2025. PMID: 39853337
-
Streamlining the Non-operative Management of Adhesive Small Bowel Obstruction: A Closed-Loop Audit Evaluating the Introduction of a Standardised Gastrografin Protocol in a District General Hospital.Cureus. 2024 Nov 9;16(11):e73327. doi: 10.7759/cureus.73327. eCollection 2024 Nov. Cureus. 2024. PMID: 39524175 Free PMC article.
-
Are the systemic immune-inflammation index and panimmune-inflammation value predictive indicators for the decision of operative treatment in adhesive small bowel obstruction?Ulus Travma Acil Cerrahi Derg. 2025 Feb;31(2):148-154. doi: 10.14744/tjtes.2025.59933. Ulus Travma Acil Cerrahi Derg. 2025. PMID: 39963915 Free PMC article.
References
-
- Ten Broek RPG, Krielen P, Di Saverio S, Coccolini F, Biffl WL, Ansaloni L, Velmahos GC, Sartelli M, Fraga GP, Kelly MD, Moore FA, Peitzman AB, Leppaniemi A, Moore EE, Jeekel J, Kluger Y, Sugrue M, Balogh ZJ, Bendinelli C, Civil I, Coimbra R, De Moya M, Ferrada P, Inaba K, Ivatury R, Latifi R, Kashuk JL, Kirkpatrick AW, Maier R, Rizoli S, Sakakushev B, Scalea T, Søreide K, Weber D, Wani I, Abu-Zidan FM, De’Angelis N, Piscioneri F, Galante JM, Catena F, van Goor H (2018) Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg 13:24. 10.1186/s13017-018-0185-2 - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical